Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot Study

Anti–tumor necrosis factor (TNF) therapy is effective in inducing remission in Crohn's disease in 60% of patients. No serological biomarkers are available, which can predict response to anti-TNF. We aimed to investigate serological markers of collagen turnover reflecting tissue inflammation as...

Descripción completa

Detalles Bibliográficos
Autores principales: van Haaften, Wouter T., Mortensen, Joachim H., Dige, Anders K., Grønbæk, Henning, Hvas, Christian L., Bay-Jensen, Anne-Christine, Karsdal, Morten A., Olinga, Peter, Manon-Jensen, Tina, Dijkstra, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494148/
https://www.ncbi.nlm.nih.gov/pubmed/33094957
http://dx.doi.org/10.14309/ctg.0000000000000217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494148/
https://www.ncbi.nlm.nih.gov/pubmed/33094957
http://dx.doi.org/10.14309/ctg.0000000000000217

Ejemplares similares